| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 24.45▲ | 24.34▲ | 24.20▲ | 23.85▲ | 25.05▼ |
| MA10 | 24.32▲ | 24.08▲ | 24.10▲ | 24.28▼ | 25.01▼ |
| MA20 | 24.13▲ | 24.11▲ | 24.07▲ | 25.26▼ | N/A |
| MA50 | 24.10▲ | 23.78▲ | 24.19▲ | 25.05▼ | N/A |
| MA100 | 23.80▲ | 24.86▲ | 25.23▼ | N/A | N/A |
| MA200 | 24.83▲ | 25.37▼ | 24.83▲ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.073▲ | 0.062▲ | 0.094▲ | -0.200▼ | N/A |
| RSI | 62.637▲ | 61.709▲ | 59.726▲ | 46.479▼ | 57.149▲ |
| STOCH | 95.766▲ | 70.321 | 60.314 | 29.430 | N/A |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -69.981 | -78.284▼ |
| CCI | 196.372▲ | 245.748▲ | 247.086▲ | -40.680 | -111.029▼ |
|
Thursday, August 14, 2025 01:20 PM
Tvardi Therapeutics, Inc. ("Tvardi") (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat ...
|
|
Thursday, August 14, 2025 10:49 AM
Detailed price information for Tvardi Therapeutics Inc (TVRD-Q) from The Globe and Mail including charting and trades.
|
|
Tuesday, July 15, 2025 12:00 AM
Detailed price information for Tvardi Therapeutics Inc (TVRD-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 24.59 | 24.62 | 23.86 | 24.00 | 11,228 |
| 14/08/25 | 22.91 | 24.05 | 22.91 | 23.79 | 11,107 |
| 13/08/25 | 24.5544 | 24.5544 | 23.70 | 23.74 | 17,357 |
| 12/08/25 | 23.46 | 25.00 | 23.46 | 23.60 | 21,715 |
| 11/08/25 | 23.86 | 24.13 | 22.86 | 24.13 | 32,611 |
| 08/08/25 | 23.36 | 24.893 | 22.40 | 23.925 | 14,100 |
| 07/08/25 | 24.34 | 24.34 | 22.835 | 23.12 | 13,819 |
| 06/08/25 | 25.49 | 25.49 | 23.84 | 24.14 | 22,450 |
| 05/08/25 | 25.6606 | 26.23 | 24.8804 | 25.99 | 43,775 |
| 04/08/25 | 26.34 | 27.73 | 25.46 | 26.34 | 35,877 |
|
|
||||
|
|
||||
|
|